Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pediatrix Medical (MD) Restructuring Costs (2019 - 2025)

Pediatrix Medical (MD) has disclosed Restructuring Costs for 7 consecutive years, with $5.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Restructuring Costs fell 75.13% to $5.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $22.3 million, a 65.34% decrease, with the full-year FY2025 number at $22.3 million, down 65.34% from a year prior.
  • Restructuring Costs was $5.9 million for Q4 2025 at Pediatrix Medical, down from $6.0 million in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $23.6 million in Q4 2024 to a low of $977000.0 in Q3 2022.
  • A 5-year average of $8.1 million and a median of $5.9 million in 2025 define the central range for Restructuring Costs.
  • Peak YoY movement for Restructuring Costs: tumbled 88.66% in 2023, then soared 965.39% in 2024.
  • Pediatrix Medical's Restructuring Costs stood at $3.1 million in 2021, then skyrocketed by 540.16% to $19.6 million in 2022, then crashed by 88.66% to $2.2 million in 2023, then skyrocketed by 965.39% to $23.6 million in 2024, then tumbled by 75.13% to $5.9 million in 2025.
  • Per Business Quant, the three most recent readings for MD's Restructuring Costs are $5.9 million (Q4 2025), $6.0 million (Q3 2025), and $3.8 million (Q2 2025).